Related Experiment Video
Updated: May 26, 2026
06:16
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
Understanding implementation processes of clinical pathways and clinical practice guidelines in pediatric contexts: a
Shannon D Scott1, Jeremy Grimshaw, Terry P Klassen
1Faculty of Nursing, University of Alberta, Edmonton, AB, Canada. shannon.scott@ualberta.ca
Implementation Science : IS
|December 30, 2011
Summary
Improving pediatric health in Canada requires better knowledge translation (KT) to reduce clinical practice variation. This study evaluates strategies to enhance KT and improve health outcomes for children facing common acute conditions.
Area of Science:
- Pediatric Health Outcomes
- Healthcare Quality Improvement
- Knowledge Translation Research
Background:
- Canadian children exhibit poor health outcomes despite national prosperity.
- Clinical practice variation, linked to poor knowledge translation (KT), contributes to these outcomes.
- This variation leads to unnecessary treatments, suffering, and increased healthcare costs.
Purpose of the Study:
- To evaluate strategies aimed at improving KT.
- To reduce clinical practice variation in pediatric care.
- To enhance health outcomes for common acute pediatric conditions.
Main Methods:
- A multiple case study design across four western Canadian emergency departments.
- Collection of qualitative and quantitative data, including focus groups, interviews, surveys (Alberta Context Tool), and patient outcomes.
- Systematic triangulation of data and cross-case comparison to analyze guideline and pathway implementation.
Main Results:
- Analysis of qualitative and quantitative data to understand factors influencing implementation success or failure.
- Identification of causal mechanisms and contextual factors shaping the uptake of clinical practice guidelines and pathways.
- Data collection on Alberta Context Tool survey results and aggregated patient outcomes.
Conclusions:
- This study will generate novel insights into the mechanisms and factors driving implementation.
- Future research will assess the impact of implemented guidelines and pathways on pediatric health and healthcare costs.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...